2m 2m 2m 2m 2m 2m 2m
Aurinia Pharma (AUPH)
NASDAQ
$17.98+$0.45 (+2.54%)
Price as of Jun 23, 2026 7:56 PM EDT- $2.3BMarket Cap
- 123.88%1-Year Change
- BiotechnologyIndustry
Aurinia Pharma (AUPH)
$17.98+$0.45 (+2.54%)
AUPH | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $17.53 | ||
Change | +$1.07 (+6.50%) | ||
Open | $17.35 | ||
High | $18.40 | ||
Low | $17.16 | ||
Previous Close | $16.46 | ||
Volume | 3,393,739 | ||
30-Day Average Volume | 1,346,861 | ||
1-Week Change | 9.56% | ||
1-Month Change | 15.18% | ||
1-Year Change | 123.88% | ||
3-Year Change | 84.14% | ||
5-Year Change | 25.12% | ||
Fundamentals | |||
Shares Outstanding | 128.6M | ||
Total Assets | $724.0M | ||
Market Cap | $2.3B | ||
Enterprise Value | $2.2B | ||
Period: QTR TTM FY | |||
Revenue | $73.6M | ||
Net Income | $34.4M | ||
Free Cash Flow | $8.9M | ||
EBIT | $43.9M | ||
EBITDA | $48.7M | ||
Net Working Capital | $393.7M | ||
EPS | $0.25 | ||
Enterprise Value/EBITDA | 45 | ||
Enterprise Value/Revenue | 30 | ||
P/B | 4 | ||
P/E | 70 | ||
PEG | -1 | ||
Price/Free Cash Flow | 254 | ||
Price/Operating Cash Flow | 69 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue